Peter P. Pfreundschuh - Net Worth and Insider Trading

Peter P. Pfreundschuh Net Worth

The estimated net worth of Peter P. Pfreundschuh is at least $1 Million dollars as of 2024-12-01. Peter P. Pfreundschuh is the CFO of Voyager Therapeutics Inc and owns about 175,669 shares of Voyager Therapeutics Inc (VYGR) stock worth over $1 Million. Peter P. Pfreundschuh is the CFO of UroGen Pharma Ltd and owns about 10,405 shares of UroGen Pharma Ltd (URGN) stock worth over $132,144. Peter P. Pfreundschuh is also the CFO of Frequency Therapeutics Inc and owns about 8,927 shares of Frequency Therapeutics Inc (FREQ) stock worth over $2,675. Details can be seen in Peter P. Pfreundschuh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter P. Pfreundschuh has not made any transactions after 2024-02-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter P. Pfreundschuh

To

Peter P. Pfreundschuh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter P. Pfreundschuh owns 6 companies in total, including UroGen Pharma Ltd (URGN) , Sucampo Pharmaceuticals Inc (SCMP) , and Immunomedics Inc (IMMU) among others .

Click here to see the complete history of Peter P. Pfreundschuh’s form 4 insider trades.

Insider Ownership Summary of Peter P. Pfreundschuh

Ticker Comapny Transaction Date Type of Owner
URGN UroGen Pharma Ltd 2020-10-15 CFO
SCMP Sucampo Pharmaceuticals Inc 2018-02-13 CFO
IMMU Immunomedics Inc 2015-08-20 Chief Financial Officer
LIMIT LIMIT 2022-02-22 Chief Financial Officer
LIMIT LIMIT 2024-02-21 Chief Financial Officer
LIMIT LIMIT 2020-12-01 Chief Financial Officer

Peter P. Pfreundschuh Latest Holdings Summary

Peter P. Pfreundschuh currently owns a total of 3 stocks. Among these stocks, Peter P. Pfreundschuh owns 175,669 shares of Voyager Therapeutics Inc (VYGR) as of February 21, 2024, with a value of $1 Million and a weighting of 89.94%. Peter P. Pfreundschuh owns 10,405 shares of UroGen Pharma Ltd (URGN) as of October 15, 2020, with a value of $132,144 and a weighting of 9.86%. Peter P. Pfreundschuh also owns 8,927 shares of Frequency Therapeutics Inc (FREQ) as of February 22, 2022, with a value of $2,675 and a weighting of 0.2%.

Latest Holdings of Peter P. Pfreundschuh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VYGR Voyager Therapeutics Inc 2024-02-21 175,669 6.86 1,205,089
URGN UroGen Pharma Ltd 2020-10-15 10,405 12.70 132,144
FREQ Frequency Therapeutics Inc 2022-02-22 8,927 0.30 2,675

Holding Weightings of Peter P. Pfreundschuh


Peter P. Pfreundschuh Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter P. Pfreundschuh has made a total of 2 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Voyager Therapeutics Inc is the sale of 3,764 shares on February 21, 2024, which brought Peter P. Pfreundschuh around $28,079.

According to the SEC Form 4 filings, Peter P. Pfreundschuh has made a total of 7 transactions in UroGen Pharma Ltd (URGN) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in UroGen Pharma Ltd is the sale of 2,400 shares on October 15, 2020, which brought Peter P. Pfreundschuh around $52,248.

According to the SEC Form 4 filings, Peter P. Pfreundschuh has made a total of 3 transactions in Frequency Therapeutics Inc (FREQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Frequency Therapeutics Inc is the sale of 2,946 shares on February 22, 2022, which brought Peter P. Pfreundschuh around $10,871.

Insider Trading History of Peter P. Pfreundschuh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter P. Pfreundschuh Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter P. Pfreundschuh Ownership Network

Ownership Network List of Peter P. Pfreundschuh

No Data

Ownership Network Relation of Peter P. Pfreundschuh

Insider Network Chart

Peter P. Pfreundschuh Owned Company Details

What does UroGen Pharma Ltd do?

Who are the key executives at UroGen Pharma Ltd?

Peter P. Pfreundschuh is the CFO of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include General Counsel Jason Drew Smith , Chief Medical Officer Mark Schoenberg , and Chief Financial Officer Dong Kim .

UroGen Pharma Ltd (URGN) Insider Trades Summary

Over the past 18 months, Peter P. Pfreundschuh made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 25,590 shares made by Mark Schoenberg , and a net sale of 15,307 shares made by Jason Drew Smith .

In summary, during the past 3 months, insiders sold 2,380 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 2,380 shares. During the past 18 months, 40,897 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,897 shares.

UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

UroGen Pharma Ltd Insider Transactions

No Available Data

Peter P. Pfreundschuh Mailing Address

Above is the net worth, insider trading, and ownership report for Peter P. Pfreundschuh. You might contact Peter P. Pfreundschuh via mailing address: C/o Immunomedics, Inc., 300 The American Road, Morris Plains Nj 07950.

Discussions on Peter P. Pfreundschuh

No discussions yet.